BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15983901)

  • 1. Modulation of infection with Histoplasma capsulatum by inhibition of tumor necrosis factor-alpha activity.
    Deepe GS
    Clin Infect Dis; 2005 Aug; 41 Suppl 3():S204-7. PubMed ID: 15983901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-alpha plays a critical role in maintaining secondary immunity in the absence of IFN-gamma.
    Zhou P; Miller G; Seder RA
    J Immunol; 1998 Feb; 160(3):1359-68. PubMed ID: 9570555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of endogenous TNF-alpha exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms.
    Allendoerfer R; Deepe GS
    J Immunol; 1998 Jun; 160(12):6072-82. PubMed ID: 9637524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-alpha and host resistance to the pathogenic fungus, Histoplasma capsulatum.
    Deepe GS
    J Investig Dermatol Symp Proc; 2007 May; 12(1):34-7. PubMed ID: 17502867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy.
    Wood KL; Hage CA; Knox KS; Kleiman MB; Sannuti A; Day RB; Wheat LJ; Twigg HL
    Am J Respir Crit Care Med; 2003 May; 167(9):1279-82. PubMed ID: 12615627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance mechanisms in murine experimental histoplasmosis.
    Wu-Hsieh BA
    Arch Med Res; 1993; 24(3):233-8. PubMed ID: 7905306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-alpha antagonism by the murine tumor necrosis factor-alpha receptor 2-Fc fusion protein exacerbates histoplasmosis in mice.
    Deepe GS
    J Interferon Cytokine Res; 2007 Jun; 27(6):471-80. PubMed ID: 17572011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivation histoplasmosis after treatment with anti-tumor necrosis factor alpha in a patient from a nonendemic area.
    Jain VV; Evans T; Peterson MW
    Respir Med; 2006 Jul; 100(7):1291-3. PubMed ID: 16545951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha plays a role in host defense against Histoplasma capsulatum.
    Smith JG; Magee DM; Williams DM; Graybill JR
    J Infect Dis; 1990 Dec; 162(6):1349-53. PubMed ID: 2230264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis modulates protective immunity to the pathogenic fungus Histoplasma capsulatum.
    Allen HL; Deepe GS
    J Clin Invest; 2005 Oct; 115(10):2875-85. PubMed ID: 16151533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cells require tumor necrosis factor-alpha to provide protective immunity in mice infected with Histoplasma capsulatum.
    Deepe GS; Gibbons RS
    J Infect Dis; 2006 Jan; 193(2):322-30. PubMed ID: 16362898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective and memory immunity to Histoplasma capsulatum in the absence of IL-10.
    Deepe GS; Gibbons RS
    J Immunol; 2003 Nov; 171(10):5353-62. PubMed ID: 14607938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab and etanercept?
    Ehlers S
    Clin Infect Dis; 2005 Aug; 41 Suppl 3():S199-203. PubMed ID: 15983900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective innate antibacterial host responses during murine Klebsiella pneumoniae bacteremia: tumor necrosis factor (TNF) receptor 1 deficiency versus therapy with anti-TNF-alpha.
    Moore TA; Lau HY; Cogen AL; Standiford TJ
    Clin Infect Dis; 2005 Aug; 41 Suppl 3():S213-7. PubMed ID: 15983903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular mediators of anti-histoplasma immunity: I. Protective immunity and cellular changes in spleens of mice immunized by sublethal infection with yeast cells of histoplasma capsulatum.
    Khardori N; von Behren L; Chaudhary S; McConnachie P; Strano A; Tewari RP
    Mykosen; 1986 Mar; 29(3):103-15. PubMed ID: 3702914
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune responses in histoplasmosis, a prototype of respiratory mycoses.
    Tewari RP; Von Behren LA
    Indian J Chest Dis Allied Sci; 2000; 42(4):265-9. PubMed ID: 15597673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Necrosis Factor Alpha Antagonism Reveals a Gut/Lung Axis That Amplifies Regulatory T Cells in a Pulmonary Fungal Infection.
    Tweedle JL; Deepe GS
    Infect Immun; 2018 Jun; 86(6):. PubMed ID: 29581197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential requirements for soluble and transmembrane tumor necrosis factor in the immunological control of primary and secondary Listeria monocytogenes infection.
    Musicki K; Briscoe H; Tran S; Britton WJ; Saunders BM
    Infect Immun; 2006 Jun; 74(6):3180-9. PubMed ID: 16714545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and in vitro activities of cell-free antigens from Histoplasma capsulatum-loaded biodegradable microspheres.
    dos Santos DF; Nicolete R; de Souza PR; Bitencourt Cda S; dos Santos RR; Bonato VL; Silva CL; Faccioli LH
    Eur J Pharm Sci; 2009 Dec; 38(5):548-55. PubMed ID: 19833200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Strategies of Histoplasma capsulatum for evading the cytocidal mechanisms of phagocytes].
    Taylor ML; Duarte-Escalante E
    Rev Invest Clin; 1995; 47(6):499-506. PubMed ID: 8850150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.